Allotex Inc. is a pioneering biologics and device company focused on developing innovative therapeutic solutions for vision correction. By utilizing precisely shaped human corneal allografts, Allotex creates a natural, removable inlay, offering patients a safe, permanent vision correction option. With a commitment to advancing vision correction, Allotex is dedicated to improving the lives of individuals affected by presbyopia and other refractive disorders of the human eye.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
12/01/23 | undisclosed | Series B |
Exor Ventures Junson Capital KCK MedTech Panakes Supernova Invest | undisclosed |